Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

In Vivo Evidence for a Role of Pyroptosis in HIV Pathogenesis

By Enthusiast Inc MDFebruary 16, 2016

30% of HIV-infected subjects fail to increase their CD4 T-cell lymphocyte counts during combination antiretroviral therapy (cART) and remain both inflamed and immunodeficient. These individuals are termed “immunological non-responders.” Systemic…

DEVELOPMENT OF VIRAL BIOMARKERS IN SHIV INFECTED NONHUMAN PRIMATES

By Jimmy He PharmD, DScApril 4, 2022

As HIV-1 infection has transformed from a fatal crisis into a chronic, life-long disease managed by anti-retroviral therapy (ART), attention has shifted towards curative therapies. A regimen which may allow…

Follicular Regulatory T Cells Are Highly Permissive to HIV-1 Ex Vivo

By Enthusiast Inc MDFebruary 16, 2016

…analyses were performed by Wilcoxon matched-pairs signed rank test using GraphPad Prism 6. %GFP+ is higher in TFR compared to TFH (median, 4.8-fold higher; p=0.008) and in GC TFR compared…

EXPANSION OF MYELOID-DERIVED SUPPRESSOR CELLS IN ART-SUPPRESSED HIV-INFECTED PATIENTS

By Enthusiast Inc MDMarch 7, 2019

…Total HIV-DNA and intracellular HIV-RNA were quantified by qPCR in purified CD4+ T cells. P24 expression and MDSC infiltration in B-cell follicles within lymph nodes of n=2 chronic infected patients…

INNATE IMPAIRMENT DURING SIV INFECTION ALTERS ZIKV VIRAL PATHOGENESIS

By Jimmy He PharmD, DScApril 4, 2022

…control animals (n=7) only infected with ZIKV (SIV-/ZIKV+). SIV and ZIKV viral loads in plasma and peripheral tissues were measured by qRT-PCR. Blood/peripheral blood mononuclear cells (PBMCs), lymph node, and…

TRANSFORMATION OF DOLUTEGRAVIR INTO A YEAR-LONG PARENTERAL PRODRUG FORMULATION

By Jimmy He PharmD, DScApril 4, 2022

Antiretroviral therapy (ART) requires lifelong daily dosing to attain durable viral suppression. However, regimen adherence dictates effective long-term clinical response by precluding viral rebound. To improve ART effectiveness and ensure…

HIV NONHUMAN PRIMATE MODELS FOR STUDIES OF VIRUS PATHOGENESIS, PERSISTENCE, AND CURE

By Jimmy He PharmD, DScApril 4, 2022

…to eliminate abnormal and/or infected cells, through distinct mechanisms, including ADCC. Studies of macaques and AGM chronically infected by SIV have revealed the presence of adaptive and memory NK cells….

444 – RV550: IL-15 Superagonist N-803 With ART in Acute HIV Infection Enhances T and NK Cell Proliferation

By Jimmy He PharmD, DScMarch 20, 2025

…the effects of N-803 on T cells and NK cells in peripheral blood (PBMC) and lymph nodes (LN). Methods Participants with AHI (Fiebig I-IV) were randomized in an open-label manner…

309 – IL-15 Superagonist at ART Initiation Expands SIV-Specific CD8+ T Cells in Blood and Lymphoid Tissues

By Jimmy He PharmD, DScMarch 31, 2026

…were measured by ddPCR and cellular immune dynamics by flow cytometry. Results IL-15SA treatment transiently increased frequencies of total memory CD8+ and SIV Gag CM9-specific CD8+ T cells in blood…

310 – Dual IL-21/IL-15 Enhances CD8 T- and NK-Cell Function, Promoting Viral Control Post-ART Interruption

By Jimmy He PharmD, DScMarch 31, 2026

…As such, developing interventions aimed at improving immune responses is a key priority for HIV cure strategies. Here, we investigated the effects of a combined heterodimeric IL-15 (hetIL-15) and IL-21 treatment….

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273
…7475767778…
79808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top